PHILADELPHIA, PA — HealthVerity, the leader in synchronizing transformational technologies and real-world data (RWD) to advance the science, today announced the launch of HealthVerity FLOW, a pharma-class Software-as-a-Service solution that enables pharmaceutical manufacturers to integrate extensive RWD capabilities with patient-centric compliance across the full spectrum of registries, clinical trials and commercial activities. HealthVerity FLOW is the ideal choice for data-driven companies seeking to unify and accelerate the process for building more comprehensive patient journeys in a highly accurate, privacy protecting manner while also ensuring that data rights and data management are governed uniformly across the enterprise.

Pharmaceutical companies have traditionally invested billions of dollars in registries and clinical trials to collect first-party data from patients on a blinded basis. This technique insulated sponsors from more complex data compliance issues, but ultimately limited the speed and quality of patient analytics that could be conducted in advance of initial regulatory submissions or applications for new indications. Advances in data science, however, combined with the breadth of HIPAA-compliant data now available, have prompted a movement by market leaders to seek approval from Institutional Review Boards (IRBs) to benefit from these trends. This is further supported by regulatory agencies that are increasingly more accepting of RWD, with appropriate provenance, as an important component in regulatory filings. Despite the momentum, companies are struggling with the burdens of effectively managing patient permissions, discovering and sourcing third-party patient data, governing the exchange of data between sources and researchers, and managing the complex workflows across numerous registries, clinical trials and commercial initiatives.

HealthVerity FLOW is already experiencing rapid adoption among top 20 pharma organizations due to a modular platform that synchronizes leading technologies for identity, privacy and governance with the nation’s largest healthcare and consumer data ecosystem. HealthVerity FLOW enables customers to move beyond legacy tokenization and to establish a unique, but persistent source of truth for patients enrolled in registries and studies. By managing identity with 10x greater accuracy than legacy technologies, HealthVerity FLOW can more effectively orchestrate all types of RWD collection and exchange, all within a HIPAA and 21 CFR 11-compliant environment that delivers regulatory-ready data in real-time across the most critical use cases. The flexibility of the HealthVerity FLOW infrastructure makes it ideal to power patient-centric efforts through all phases of therapeutic development while offering a RWD-driven alternative for patients lost to follow up, safety surveillance and pursuit of real-world evidence for new indications.

”HealthVerity FLOW is remarkable in its ability to simplify and streamline the capture, compliance and study of comprehensive patient journeys before, during and after clinical trials,” said Andrew Kress, CEO of HealthVerity. “The promise of broad-scale adoption of a solution that leverages advanced technologies for enriching first-party clinical data with RWD should enhance the quality of regulatory submissions, reduce time to approval and significantly improve patient outcomes in the future.”

HealthVerity is hosting a webinar introducing HealthVerity FLOW on May 23 at 12:00 p.m. Interested parties may register here with replays available on May 24 in our Resource Library.

About HealthVerity

HealthVerity synchronizes transformational technologies with the nation’s largest healthcare and consumer data ecosystem to power previously unattainable outcomes and fundamentally advance the science. We offer a comprehensive, yet flexible approach, based on the foundational elements of Identity, Privacy, Governance and Exchange (IPGE), that synchronizes unparalleled Identity management with built-in Privacy compliance and Governance, providing the ability to discover and Exchange a near limitless combination of data at a record pace. Together with our partners in life sciences, government and insurance, we are Synchronizing the Science. To learn more about HealthVerity, visit healthverity.com.

HealthVerity Contact

Colleen Stoker
614-738-0592
cstoker@healthverity.com

BERKELY HEIGHTS, NJ & PHILADELPHIA, PA — Axtria, Inc., a global leader of award-winning cloud software and data analytics, and HealthVerity, the leader in Identity, Privacy, Governance, and Exchange (IPGE) for real-world data, today announced a partnership to provide life sciences organizations with the data, analytics and infrastructure required to enable comprehensive and privacy-compliant views of patient journeys across all engagement channels.

“This partnership combines our best-in-class patient identity resolution technology, consent management solutions and real-world data ecosystem with Axtria’s leading analytics capabilities to fundamentally change how life sciences organizations interact with patients,” said HealthVerity CEO Andrew Kress. “We are excited to offer unprecedented insight into the patient journey and unlock significantly more bandwidth for our clients to innovate.”

The HealthVerity IPGE platform is an integrated technology and real-world data (RWD) infrastructure that allows disparate data to be accurately resolved to unique privacy-protected identities, then connected in a HIPAA-compliant manner, enabling interoperability with the nation’s largest healthcare and consumer data ecosystem. This partnership allows the power of the HealthVerity data ecosystem to be applied to Axtria’s analytics products and services to solve real-world problems, driving breakthroughs in artificial intelligence (AI) and machine learning (ML).

“For life sciences companies, successfully competing in today’s environment requires a deep understanding of the patient journey and their ever-changing needs. This is only possible when the best data is combined with the best analytics and seamless delivery of insights in real-time,” said Axtria CEO Jaswinder Chadha. “Axtria has always been at the forefront of clinical and commercial innovation, and this partnership is another step in that direction, so our customers are equipped to win in a highly competitive landscape where winners will be decided based on how well they understand and solve patient needs.”

Through this partnership, Axtria and HealthVerity will offer best-in-class solutions to help drive clinical and commercial impact. Specifically, they will enable companies to manage patient identities and consent and, as appropriate, capture and match patient-level data across engagement channels, such as advertising, specialty pharmacies and hubs, patient support programs and other digital applications—all in a HIPAA-compliant manner. On top of this infrastructure, they will apply advanced analytics for applications such as trigger programs that inform next-best actions and closed-loop media attribution that links marketing campaigns to actual patient behavior.

About HealthVerity

Pharmaceutical manufacturers, payers, and government organizations have partnered with HealthVerity to solve some of their most complicated use cases through transformative technologies and real-world data infrastructure. The HealthVerity IPGE platform, based on the foundational elements of Identity, Privacy, Governance, and Exchange, enables the discovery of real-world data across the broadest healthcare data ecosystem, the building of more complete and accurate patient journeys and the ability to power best-in-class analytics and applications with flexibility and ease. Together with our partners, HealthVerity has built the modern way to data for the health insights economy. To learn more about the HealthVerity IPGE platform, visit www.healthverity.com.

About Axtria

Axtria is a global provider of award-winning cloud software and data analytics to the life sciences industry. Axtria’s solutions are used to digitally transform the entire product commercialization process, supporting RWE/HEOR, medical affairs, pricing and market access, product launch, and post-launch, and marketing and sales operations to drive growth and improve healthcare outcomes for patients. Our focus is on delivering solutions that help pharmaceutical, medical device, and diagnostics companies complete the journey from data to insights to action and get superior returns from their investments. For more information, visit www.axtria.com.

HealthVerity Contact

Colleen Stoker
614-738-0592
cstoker@healthverity.com

Axtria Contact

Jennifer Salah
877-929-8742
connect@axtria.com

PHILADELPHIA, PA — HealthVerity, the leader in Identity, Privacy, Governance and Exchange (IPGE) for real-world data (RWD), announced that it entered into a feasibility study with the Food and Drug Administration’s (FDA’s) Sentinel Innovation Center, a national program led by Mass General Brigham and Harvard Pilgrim Health Care Institute that uses electronic health data for over 100 million people to monitor the safety of FDA-regulated drugs and other medical products.

Launched in 2008, the Sentinel Initiative has continued to grow and evolve, transforming the way researchers monitor the safety of FDA-regulated products and becoming the largest curated database in the world dedicated to medical product safety. In 2019, the Innovation Center was created as part of the Sentinel Initiative to explore methods for incorporating linked medical claims and electronic health record (EHR) data into the Sentinel System for 10 million lives within five years. EHR data provides more clinical detail than insurance claims and is expected to address current gaps in the Sentinel System’s capabilities.

HealthVerity was selected to participate in this undertaking. During the 14-month project, select EHR data from the vast HealthVerity data ecosystem, consisting of over 75 unique data sources representing more than 330 million de-identified patients, will be converted into the Sentinel Common Data Model, and evaluated to ensure the data is fit for purpose.

“HealthVerity is honored to be a part of this groundbreaking initiative supporting the FDA’s goal to incorporate EHR data into the Sentinel System,” said Andrew Kress, CEO, and co-founder of HealthVerity. “We look forward to working with the Sentinel team during this project and identifying important future collaborations.”

About HealthVerity

Pharmaceutical manufacturers, payers, and government organizations have partnered with HealthVerity to solve some of their most complicated use cases through transformative technologies and real-world data infrastructure. The HealthVerity IPGE platform, based on the foundational elements of Identity, Privacy, Governance, and Exchange, enables the discovery of real-world data across the broadest healthcare data ecosystem, the building of more complete and accurate patient journeys and the ability to power best-in-class analytics and applications with flexibility and ease. Together with our partners, HealthVerity has built the modern way to data for the health insights economy. To learn more about the HealthVerity IPGE platform, visit www.healthverity.com.

CHICAGO, IL and PHILADELPHIA, PA — Veradigm^®, a leading provider of healthcare data and technology solutions (NASDAQ: MDRX), and HealthVerity^®, a leader in Identity, Privacy, Governance, and Exchange (IPGE) for real-world data, today announced a collaboration that will advance real-world research and improve patient care for those with cardiovascular disease and diabetes. The collaboration makes Veradigm’s data from their Cardiovascular and Metabolic Registries fully interoperable with de-identified patient data from HealthVerity Marketplace, the nation’s largest healthcare and consumer data ecosystem.

The HealthVerity IPGE platform is an integrated technology and real-world data (RWD) infrastructure that allows disparate data to be accurately resolved to unique privacy-protected identities, then linked in a HIPAA-compliant manner and exchanged for a myriad of use cases. By connecting Veradigm’s Cardiology and Metabolic registries with broad scale healthcare and consumer data from HealthVerity, the collaboration provides clinical researchers with unprecedented access to regulatory-quality, HIPAA-compliant and research-ready data to advance analytics and treatments for these prevalent conditions.

The Veradigm Cardiology Registry is the largest U.S. outpatient cardiovascular quality improvement registry, with 102+ million records, representing 18.9+ million unique patient lives, 13,000 providers and 4,000 office locations. The registry captures data on coronary artery disease (CAD), heart failure (HF), atrial fibrillation (AF), hypertension (HTN) and peripheral arterial disease (PAD). It follows cardiac patients across their journey, tracking key measures, including patient demographics, plan of care, cardiac events and comorbidities, exams, procedures, lab values, related medications, and more.

The Veradigm Metabolic Registry is the first clinical ambulatory registry aimed at tracking and improving the quality of prediabetes, diabetes, and cardiometabolic care across the primary and specialty care continuum. The registry has 79+ million records, representing 13.5+ million unique patient lives, 11,100 providers, and 3,400 office locations. Key measures captured include patient demographics, A1c control, nephropathy, blood cholesterol, hypertension eye exam, foot exam, antiplatelet therapy and more. Additionally, Veradigm’s electronic health record (EHR) data from the most recent five years is incorporated, representing over 176 million patients with clinical activity, as well as Veradigm medical claims and remittance data for 300 million medical claims captured in a rolling two-year period.

“Veradigm provides life science researchers scalable access to real-world clinical data via our direct connection with the point-of-care,” said Stuart Green, Senior Vice President and General Manager, Veradigm. “With Veradigm’s Registry and EHR data on the HealthVerity platform, we are extending the reach of the Veradigm Network to further support improvements in patient care at scale.”

The collaboration between Veradigm and HealthVerity leverages the industry’s most accurate patient matching and identity resolution technology, a key component of the HealthVerity IPGE Platform, which will allow researchers to discover more comprehensive longitudinal patient journeys without the patient fragmentation inherent in more traditional patient tokenization solutions.

“Diabetes is a top driver of healthcare spend and, as we enter Heart Health Month, we are reminded of the need for comprehensive treatments for heart disease, a leading cause of death in the United States,” said Andrew Kress, CEO of HealthVerity. “This collaboration will enable far greater contextualization of important registry data and will provide a more holistic view of these patients’ journeys. Life Sciences organizations and clinical researchers can now obtain comprehensive patient-level data in a privacy-protected manner that offers real-world insight into the patient to ultimately improve care for these ubiquitous conditions.”

About Veradigm

Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions, all working together to transform healthcare insightfully. For more information on Veradigm, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, and YouTube

About HealthVerity

Pharmaceutical manufacturers, payers, and government organizations have partnered with HealthVerity to solve some of their most complicated use cases through transformative technologies and real-world data infrastructure. The HealthVerity IPGE platform, based on the foundational elements of Identity, Privacy, Governance, and Exchange, enables the discovery of real-world data across the broadest healthcare data ecosystem, the building of more complete and accurate patient journeys and the ability to power best-in-class analytics and applications with flexibility and ease. Together with our partners, HealthVerity has built the modern way to data for the health insights economy. To learn more about the HealthVerity IPGE platform, visit www.healthverity.com.

Contact

Veradigm
Investors:
Jenny Gelinas
312-506-1237
jenny.gelinas@veradigm.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@veradigm.com

HealthVerity
Colleen Stoker
cstoker@healthverity.com

NEW YORK, NY — Lumanity and HealthVerity today announced a strategic partnership that will enable life sciences companies to derive better outcomes from the HealthVerity IPGE platform, including the nation’s largest, fully-interoperable healthcare and consumer data ecosystem, in combination with Lumanity’s world-class data and real-world evidence (RWE) generation expertise. The partnership creates tremendous value for clients seeking to leverage Lumanity’s unique ability to identify the optimal, research-ready real-world data (RWD) to support real-world research, as well as its strengths in global health economics and outcomes research (HEOR), safety, and data analytics.

“We are thrilled to partner with HealthVerity as part of the launch of our global RWE practice,” said Gema Parlange, Chief Commercial and Development Officer and the Global Practice Lead for RWE at Lumanity. “We are very impressed with the depth and breadth of the HealthVerity IPGE platform, including its highly accurate patient identity resolution technology and broad ecosystem of data partners, and are excited about the possibilities of bringing multi-source, cohort-specificity together with our deep domain expertise in HEOR and Value Demonstration. We look forward to working together to provide innovative new solutions for our clients and partners.”

The HealthVerity IPGE platform is an integrated technology and RWD infrastructure based on four foundational elements, Identity, Privacy, Governance, and Exchange, that allow disparate data to be accurately resolved to unique but persistent identities, linked, and exchanged in a privacy-protected manner for a myriad of use cases. The HealthVerity RWD ecosystem supports a comprehensive array of customer use cases that leverage the convergence of medical claims data, lab data and results, pharmacy data, EMR data, hospital chargemaster data, and social determinants of health data.

“This partnership combines our 10x accuracy advantage in patient identity resolution, access to novel data assets, and Lumanity’s deep domain expertise in HEOR, value demonstration, patient-reported outcomes, and media strategy,” said Sandy Leonard, Senior Vice President of Partnerships and RWD Solutions at HealthVerity. “We believe this is a powerful combination to help our customers build more complete and accurate patient journeys to support their most pressing research and analytics projects.”

Lumanity was formed by bringing together the expertise and capabilities of several exceptional organizations, including Cello Health, BresMed, Guidemark Health, Cyan Health, Zipher Medical Affairs, Innovative Edge, Endpoint Outcomes, and Clarion. The partnership with HealthVerity comes on the heels of launching Lumanity’s Real World Evidence global practice, and further enhances Lumanity’s unique and diverse collection of deeply experienced industry pioneers, data luminaries, subject matter experts, and proven problem solvers with advanced clinical, scientific, and real-world data capabilities.

About Lumanity

Lumanity applies incisive thinking and decisive action to cut through complex situations and deliver transformative outcomes to accelerate and optimize access to medical advances. By transforming data and information into real-world insights and evidence, Lumanity powers successful commercialization and empowers patients, providers, payers, and regulators to take timely and decisive action. With offices in North America, the United Kingdom, Europe, and Asia, and work conducted in over 50 countries, its 1,300+ experts work with nearly all the top pharmaceutical and more than 100 biotech companies around the world. Turning aspiration into reality, Lumanity supports over 50 payer submissions across 20+ countries, launch readiness and commercialization of 80 brands and new indications, and numerous award-winning product campaigns every year. For more information, please visit lumanity.com and connect with Lumanity on Twitter and LinkedIn

About HealthVerity

Pharmaceutical manufacturers, payers, and government organizations have partnered with HealthVerity to solve some of their most complicated use cases through transformative technologies and real-world data infrastructure. The HealthVerity IPGE platform, based on the foundational elements of Identity, Privacy, Governance, and Exchange, enables the discovery of real-world data across the broadest healthcare data ecosystem, the building of more complete and accurate patient journeys and the ability to power best-in-class analytics and applications with flexibility and ease. Together with our partners, HealthVerity has built the modern way to data for the health insights economy. To learn more about the HealthVerity IPGE platform, visit www.healthverity.com.

Contact

Lumanity
Peter Marangos
+1 702 776 0985 / peter.marangos@lumanity.com

HealthVerity
Colleen Stoker
cstoker@healthverity.com

PHILADELPHIA, PA — (PRNewswire) — HealthVerity, Inc., the leader in Identity, Privacy, Governance and Exchange (IPGE) for real-world data, today announced that it has achieved Federal Risk and Authorization Management Program (FedRAMP) authorization at the Moderate security impact level for its Privacy-Preserving Record Linkage (PPRL) solution. At present, the FedRAMP marketplace lists 40 federal agencies that have granted HealthVerity an Authority to Operate (ATO).

HealthVerity PPRL leverages advanced identity resolution techniques to link patient records across time and data sources by creating unique but persistent identities, also called HealthVerity IDs (HVIDs). HVIDs can be used to source and study patient-centric transactions in a HIPAA-compliant manner at scale from the nation’s largest ecosystem of healthcare and consumer data. Now listed on the FedRAMP Marketplace, the HealthVerity PPRL solution can be contracted by any government agency without additional vetting required — eliminating onboarding cost and time burdens.

FedRAMP is a federal government program that promotes and provides a standardized approach to security assessment, authorization, and continuous monitoring for cloud-based information system products and services. It uses a common, standardized security framework to assess cloud products and services to ensure the cloud service provider’s (CSP’s) product and the organization’s security complies with required security standards for the protection of federal information.

“Obtaining FedRAMP certification for HealthVerity PPRL allows federal government agencies to benefit from the industry’s most accurate means to manage identity and linkage for healthcare and consumer data on a fully interoperable, privacy-protected basis,” said John Cappiello, chief technology officer for HealthVerity. “With a FedRAMP Moderate ATO, HealthVerity joins a very distinguished and select group of CSPs delivering the highest security standards in the healthcare industry.”

HealthVerity has a history of serving key government agencies to support public health initiatives. Last month, HealthVerity was awarded a contract with the National Cancer Institute (NCI) to implement a data discovery and governance platform for their National Childhood Cancer Registry (NCCR). Additionally, HealthVerity was awarded the largest-ever contract for real-world data by the Centers for Disease Control and Prevention (CDC) in September 2021 to advance COVID-19 research. The organization also supported the NCI in a groundbreaking study of SARS-CoV-2 antibodies in February 2021, announced a research contract with the U.S. Food and Drug Administration (FDA) to support a COVID-19 clinical study and treatment opportunities in June 2020, and was awarded a PPRL contract for COVID-19 vaccine data with the Department of Health and Human Services (HHS) in November 2020.

About HealthVerity

Pharmaceutical manufacturers, payers, and government organizations have partnered with HealthVerity to solve some of their most complicated use cases through transformative technologies and real-world data infrastructure. The HealthVerity IPGE platform, based on the foundational elements of Identity, Privacy, Governance, and Exchange, enables the discovery of real-world data across the broadest healthcare data ecosystem, the building of more complete and accurate patient journeys and the ability to power best-in-class analytics and applications with flexibility and ease. Together with our partners, HealthVerity has built the modern way to data for the health insights economy. To learn more about the HealthVerity IPGE platform, visit www.healthverity.com.

Contact

Jen Kaczmarczyk
Vice President of Marketing
jkaczmarczyk@healthverity.com